Abstract
Premenstrual syndrome (PMS) is a condition characterized by a combination of psychological
and physical symptoms that begin during the luteal phase of the menstrual cycle, cease
by the end of menstruation, with a symptom-free period till ovulation. A thorough
history, along with other assessment tools, both in primary care and secondary care,
is key in identifying and classifying the severity of the symptoms, which can range
from mild to very severe. Symptoms can really affect a woman's quality of life and
with up to 8% of women debilitated by severe PMS, it is vital that they are appropriately
identified using investigations available and managed accordingly. Treatment can range
from complementary therapies to hormonal and non-hormonal medication, to even surgery,
and is introduced in a step-wise manner, often involving a multidisciplinary team.
This review outlines the theories of the pathophysiology surrounding the condition,
the classification of the disease, key investigations and management options advised
in guidelines and research.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Obstetrics, Gynaecology and Reproductive MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Further reading
- Diagnostic and statistical manual of mental disorders (DSM-V).5th edn. APA, Washington DC2013
- Endicott. Using the daily record of severity of problems as a screening instrument for premenstrual syndrome.Obstet Gynecol. 2007; 109: 1068-1075
- Classification of premenstrual disorders as proposed by the international society for premenstrual disorders.Menopause Int. 2012; 18: 43-47
- Selective serotonin reuptake inhibitors for premenstual syndrome.Cochrane Database Syst Rev. 2013; 6 (CD001396)
- Consensus group of the international society for premenstrual disorders. ISPMD consensus on the management of premenstrual disorders.Arch Womens Ment Health. 2013; 16: 279-291
- Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus.Arch Womens Ment Health. 2011; 14: 13-21
- Management of premenstrual syndrome (Green-top guideline No. 48).RCOG, London2016
- Depression and hormone therapy.Clin Obstet Gynecol. 2004; 47: 428-436
- Premenstrual syndrome.Lancet. 2008; 371: 1200-1210
Article info
Publication history
Published online: July 17, 2019
Identification
Copyright
Crown Copyright © 2019 Published by Elsevier Ltd. All rights reserved.
